These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 35085602
1. Initial Experience with F(ab')2 Antivenom Compared with Fab Antivenom for Rattlesnake Envenomations Reported to a single poison center during 2019. Wilson BZ, Bahadir A, Andrews M, Karpen J, Winkler G, Smelski G, Dudley S, Walter FG, Shirazi FM. Toxicon; 2022 Apr 15; 209():10-17. PubMed ID: 35085602 [Abstract] [Full Text] [Related]
2. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')2 (equine) antivenom and crotalidae immune polyvalent Fab (ovine) antivenom reported to the North American Snakebite Sub-registry. Spyres MB, Padilla GK, Gerkin RD, Hoyte CO, Wolk BJ, Ruha AM, ToxIC Snakebite Study Group. Clin Toxicol (Phila); 2022 Jul 15; 60(7):838-842. PubMed ID: 35261320 [Abstract] [Full Text] [Related]
3. Fashionably late: A characterization of late coagulopathies in rattlesnake envenomations between Fab and F(ab')2 antivenoms. Dudley S, Smelski G, Massey DJ, Maciulewicz T, Cardwell MD, Shirazi FM. Toxicon; 2022 Jun 15; 212():49-54. PubMed ID: 35413335 [Abstract] [Full Text] [Related]
4. Comparison of F(ab')2 and Fab antivenoms in rattlesnake envenomation: First year's post-marketing experience with F(ab')2 in New Mexico. Mascarenas DN, Fullerton L, Smolinske SC, Warrick BJ, Seifert SA. Toxicon; 2020 Oct 30; 186():42-45. PubMed ID: 32763251 [Abstract] [Full Text] [Related]
6. Use of both Fab and F(ab')2 fragment antivenom in a pediatric patient for treatment of a North American Crotalidae envenomation. Martin AM, Wang GS, Poel K. Am J Emerg Med; 2021 Jul 01; 45():677.e1-677.e3. PubMed ID: 33293188 [Abstract] [Full Text] [Related]
7. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Lavonas EJ, Gerardo CJ, O'Malley G, Arnold TC, Bush SP, Banner W, Steffens M, Kerns WP. Ann Emerg Med; 2004 Feb 01; 43(2):200-6. PubMed ID: 14747809 [Abstract] [Full Text] [Related]
8. Control of venom-induced tissue injury in copperhead snakebite patients: a post hoc sub-group analysis of a clinical trial comparing F(ab')2 to Fab antivenom. Gerardo CJ, Keyler DE, Rapp-Olson M, Dart RC. Clin Toxicol (Phila); 2022 Apr 01; 60(4):521-523. PubMed ID: 34590543 [Abstract] [Full Text] [Related]
9. Total CroFab and Anavip Antivenom Vial Administration in US Rattlesnake Envenomations: 2019-2021. Brandehoff N, Dalton A, Daugherty C, Dart RC, Monte AA, ToxIC Snakebite Study Group. J Med Toxicol; 2023 Jul 01; 19(3):248-254. PubMed ID: 37115482 [Abstract] [Full Text] [Related]
10. Early Experience with Crotalidae Immune F(ab')2 Antivenom to Treat Arizona Rattlesnake Envenomations. Ruha AM, Padilla-Jones A, Canning J, Spyres MB, Curry SC. J Med Toxicol; 2022 Jan 01; 18(1):38-42. PubMed ID: 34665424 [Abstract] [Full Text] [Related]
11. Characterization of hypofibrinogenemia following rattlesnake envenomation treated with crotalidae immune F(ab')2 (equine) antivenom. Maciulewicz TS, Axon DR, Shirazi FM. Clin Toxicol (Phila); 2024 Nov 01; 62(11):749-753. PubMed ID: 39318272 [Abstract] [Full Text] [Related]
12. Failure of Crotalidae Immune F(ab')2 Equine Antivenom to Achieve Control in a Southern Pacific Rattlesnake Envenomation. Levine M, Spungen H, Pizon AF. Ann Emerg Med; 2022 Dec 01; 80(6):525-527. PubMed ID: 35953386 [Abstract] [Full Text] [Related]
13. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Bush SP, Ruha AM, Seifert SA, Morgan DL, Lewis BJ, Arnold TC, Clark RF, Meggs WJ, Toschlog EA, Borron SW, Figge GR, Sollee DR, Shirazi FM, Wolk R, de Chazal I, Quan D, García-Ubbelohde W, Alagón A, Gerkin RD, Boyer LV. Clin Toxicol (Phila); 2015 Jan 01; 53(1):37-45. PubMed ID: 25361165 [Abstract] [Full Text] [Related]
14. Efficacy and safety of two Antivenoms in the treatment of eastern copperhead (Agkistrodon contortrix) envenomations in Southeast Texas. Greene S, Teshon A. J Am Coll Emerg Physicians Open; 2024 Oct 01; 5(5):e13310. PubMed ID: 39364389 [Abstract] [Full Text] [Related]
15. Use of Crotalidae equine immune F(ab')2 antivenom for treatment of an Agkistrodon envenomation. Wilson BZ, Larsen J, Smelski G, Dudley S, Shirazi FM. Clin Toxicol (Phila); 2021 Nov 01; 59(11):1023-1026. PubMed ID: 33703984 [Abstract] [Full Text] [Related]
16. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms. Boyer LV, Chase PB, Degan JA, Figge G, Buelna-Romero A, Luchetti C, Alagón A. Toxicon; 2013 Nov 01; 74():101-8. PubMed ID: 23948058 [Abstract] [Full Text] [Related]
17. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients. Bush SP, Seifert SA, Oakes J, Smith SD, Phan TH, Pearl SR, Reibling ET. Toxicon; 2013 Jul 01; 69():29-37. PubMed ID: 23474267 [Abstract] [Full Text] [Related]
18. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Gerardo CJ, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, Charlton NP, Mullins ME, Schwartz R, Denning D, Sharma K, Kleinschmidt K, Bush SP, Ryan S, Gasior M, Anderson VE, Lavonas EJ. Ann Emerg Med; 2017 Aug 01; 70(2):233-244.e3. PubMed ID: 28601268 [Abstract] [Full Text] [Related]
19. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD. Ann Emerg Med; 2002 Dec 01; 40(6):619-24. PubMed ID: 12447339 [Abstract] [Full Text] [Related]
20. Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review. Lavonas EJ, Schaeffer TH, Kokko J, Mlynarchek SL, Bogdan GM. BMC Emerg Med; 2009 Jun 22; 9():13. PubMed ID: 19545426 [Abstract] [Full Text] [Related] Page: [Next] [New Search]